{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T09:55:40Z","timestamp":1789293340517,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"DOI":"10.7759\/cureus.65366","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T12:27:25Z","timestamp":1721910445000},"source":"Crossref","is-referenced-by-count":7,"title":["The Impact of Hormonal Contraceptives on the Incidence and Progression of Cardiovascular Diseases in Women: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Joshua","family":"Asubiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2012.11.004","article-title":"History of oral contraceptive drugs and their use worldwide","volume":"27","author":"Christin-Maitre S","year":"2013","unstructured":"Christin-Maitre S. History of oral contraceptive drugs and their use worldwide. Best Pract Res Clin Endocrinol Metab. 2013, 27:3-12. 10.1016\/j.beem.2012.11.004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00264.x","article-title":"Estrogens, progestogens and thrombosis","volume":"1","author":"Rosendaal FR","year":"2003","unstructured":"Rosendaal FR, Van Hylckama Vlieg A, Tanis BC, Helmerhorst FM. Estrogens, progestogens and thrombosis. J Thromb Haemost. 2003, 1:1371-80. 10.1046\/j.1538-7836.2003.00264.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman BH","year":"2013","unstructured":"Stegeman BH, de Bastos M, Rosendaal FR, van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013, 347:f5298. 10.1136\/bmj.f5298","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-011-9182-4","article-title":"Metabolic effects of contraceptive steroids","volume":"12","author":"Sitruk-Ware R","year":"2011","unstructured":"Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord. 2011, 12:63-75. 10.1007\/s11154-011-9182-4","journal-title":"Rev Endocr Metab Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard \u00d8","year":"2012","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012, 366:2257-66. 10.1056\/NEJMoa1111840","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2017.1317339","article-title":"The use of cyproterone acetate\/ethinyl estradiol in hyperandrogenic skin symptoms - a review","volume":"22","author":"Bitzer J","year":"2017","unstructured":"Bitzer J, R\u00f6mer T, Lopes da Silva Filho A. The use of cyproterone acetate\/ethinyl estradiol in hyperandrogenic skin symptoms - a review. Eur J Contracept Reprod Health Care. 2017, 22:172-82. 10.1080\/13625187.2017.1317339","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau G","year":"2013","unstructured":"Plu-Bureau G, Maitrot-Mantelet L, Hugon-Rodin J, Canonico M. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013, 27:25-34. 10.1016\/j.beem.2012.11.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman MV","year":"2018","unstructured":"Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018, 141:287-94. 10.1002\/ijgo.12455","journal-title":"Int J Gynaecol Obstet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper NK","year":"2016","unstructured":"Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM. Progestin-only contraception and thromboembolism: a systematic review. Contraception. 2016, 94:678-700. 10.1016\/j.contraception.2016.04.014","journal-title":"Contraception"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch LS","year":"2017","unstructured":"M\u00f8rch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard \u00d8. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017, 377:2228-39. 10.1056\/NEJMoa1700732","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill A","year":"2016","unstructured":"Weill A, Dalichampt M, Raguideau F, et al.. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ. 2016, 353:i2002. 10.1136\/bmj.i2002","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011054.pub2","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach RE","year":"2015","unstructured":"Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015, 2015:CD011054. 10.1002\/14651858.CD011054.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610368670","article-title":"Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use","volume":"17","author":"Zakharova MY","year":"2011","unstructured":"Zakharova MY, Meyer RM, Brandy KR, et al.. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. Clin Appl Thromb Hemost. 2011, 17:323-31. 10.1177\/1076029610368670","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1160\/TH15-01-0045","article-title":"Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study","volume":"115","author":"Suchon P","year":"2016","unstructured":"Suchon P, Al Frouh F, Henneuse A, et al.. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study. Thromb Haemost. 2016, 115:135-42. 10.1160\/TH15-01-0045","journal-title":"Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010813.pub2","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos M","year":"2014","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014, 2014:CD010813. 10.1002\/14651858.CD010813.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c927","article-title":"Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study","volume":"340","author":"Hannaford PC","year":"2010","unstructured":"Hannaford PC, Iversen L, Macfarlane TV, Elliott AM, Angus V, Lee AJ. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study. BMJ. 2010, 340:c927. 10.1136\/bmj.c927","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6356","article-title":"Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study","volume":"349","author":"Charlton BM","year":"2014","unstructured":"Charlton BM, Rich-Edwards JW, Colditz GA, et al.. Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study. BMJ. 2014, 349:g6356. 10.1136\/bmj.g6356","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.09.042","article-title":"Contraceptive hormone use and cardiovascular disease","volume":"53","author":"Shufelt CL","year":"2009","unstructured":"Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009, 53:221-31. 10.1016\/j.jacc.2008.09.042","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-016-4143-5","article-title":"Cardiovascular disease incidence among females in South Carolina by type of oral contraceptives, 2000-2013: a retrospective cohort study","volume":"294","author":"Samson ME","year":"2016","unstructured":"Samson ME, Adams SA, Merchant AT, Maxwell WD, Zhang J, Bennett CL, Hebert JR. Cardiovascular disease incidence among females in South Carolina by type of oral contraceptives, 2000-2013: a retrospective cohort study. Arch Gynecol Obstet. 2016, 294:991-7. 10.1007\/s00404-016-4143-5","journal-title":"Arch Gynecol Obstet"},{"key":"ref20","article-title":"Medical Eligibility Criteria for Contraceptive Use","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Medical Eligibility Criteria for Contraceptive Use. World Health Organization, Geneva; 2010."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2016","volume":"65","author":"Curtis KM","year":"2016","unstructured":"Curtis KM, Tepper NK, Jatlaoui TC, et al.. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016, 65:1-103. 10.15585\/mmwr.rr6503a1","journal-title":"MMWR Recomm Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu191","article-title":"Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic","volume":"29","author":"Bahamondes L","year":"2014","unstructured":"Bahamondes L, Bottura BF, Bahamondes MV, et al.. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic. Hum Reprod. 2014, 29:2163-70. 10.1093\/humrep\/deu191","journal-title":"Hum Reprod"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2018.1550576","article-title":"Hormonal contraception in women with endometriosis: a systematic review","volume":"24","author":"Grandi G","year":"2019","unstructured":"Grandi G, Barra F, Ferrero S, Sileo FG, Bertucci E, Napolitano A, Facchinetti F. Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care. 2019, 24:61-70. 10.1080\/13625187.2018.1550576","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.2387","article-title":"Association of hormonal contraception with depression","volume":"73","author":"Skovlund CW","year":"2016","unstructured":"Skovlund CW, M\u00f8rch LS, Kessing LV, Lidegaard \u00d8. Association of hormonal contraception with depression. JAMA Psychiatry. 2016, 73:1154-62. 10.1001\/jamapsychiatry.2016.2387","journal-title":"JAMA Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski SN","year":"2010","unstructured":"Tchaikovski SN, Rosing J. Mechanisms of estrogen-induced venous thromboembolism. Thromb Res. 2010, 126:5-11. 10.1016\/j.thromres.2010.01.045","journal-title":"Thromb Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.12.009","article-title":"Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use","volume":"94","author":"Dragoman MV","year":"2016","unstructured":"Dragoman MV, Jatlaoui T, Nanda K, Curtis KM, Gaffield ME. Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use. Contraception. 2016, 94:195-201. 10.1016\/j.contraception.2015.12.009","journal-title":"Contraception"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.03.005","article-title":"Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose","volume":"165","author":"Oedingen C","year":"2018","unstructured":"Oedingen C, Scholz S, Razum O. Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose. Thromb Res. 2018, 165:68-78. 10.1016\/j.thromres.2018.03.005","journal-title":"Thromb Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-9, W64. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3233\/EFI-180221","article-title":"The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong QN","year":"2018","unstructured":"Hong QN. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inform. 2018, 34:285-91. 10.3233\/EFI-180221","journal-title":"Educ Inform"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/jech.52.12.775","article-title":"Combined oral contraceptives, smoking, and cardiovascular risk","volume":"52","author":"Farley TM","year":"1998","unstructured":"Farley TM, Meirik O, Chang CL, Poulter NR. Combined oral contraceptives, smoking, and cardiovascular risk. J Epidemiol Community Health. 1998, 52:775-85. 10.1136\/jech.52.12.775","journal-title":"J Epidemiol Community Health"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(03)00073-8","article-title":"Oral contraceptives use and the risk of myocardial infarction: a meta-analysis","volume":"68","author":"Khader YS","year":"2003","unstructured":"Khader YS, Rice J, John L, Abueita O. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception. 2003, 68:11-7. 10.1016\/s0010-7824(03)00073-8","journal-title":"Contraception"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon JP","year":"2005","unstructured":"Baillargeon JP, McClish DK, Essah PA, Nestler JE. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis. J Clin Endocrinol Metab. 2005, 90:3863-70. 10.1210\/jc.2004-1958","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg A","year":"2009","unstructured":"van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009, 339:b2921. 10.1136\/bmj.b2921","journal-title":"BMJ"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia R","year":"2013","unstructured":"Peragallo Urrutia R, Coeytaux RR, McBroom AJ, et al.. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Obstet Gynecol. 2013, 122:380-9. 10.1097\/AOG.0b013e3182994c43","journal-title":"Obstet Gynecol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.01.012","article-title":"Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives","volume":"93","author":"Dinger J","year":"2016","unstructured":"Dinger J, M\u00f6hner S, Heinemann K. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives. Contraception. 2016, 93:378-85. 10.1016\/j.contraception.2016.01.012","journal-title":"Contraception"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616683802","article-title":"Oral contraceptives and HRT risk of thrombosis","volume":"24","author":"Gialeraki A","year":"2018","unstructured":"Gialeraki A, Valsami S, Pittaras T, Panayiotakopoulos G, Politou M. Oral contraceptives and HRT risk of thrombosis. Clin Appl Thromb Hemost. 2018, 24:217-25. 10.1177\/1076029616683802","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova Y","year":"2019","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019, 364:k4810. 10.1136\/bmj.k4810","journal-title":"BMJ"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard \u00d8","year":"2011","unstructured":"Lidegaard \u00d8, Nielsen LH, Skovlund CW, Skjeldestad FE, L\u00f8kkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011, 343:d6423. 10.1136\/bmj.d6423","journal-title":"BMJ"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura M","year":"2023","unstructured":"Chakhtoura M, Haber R, Ghezzawi M, Rhayem C, Tcheroyan R, Mantzoros CS. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation. EClinicalMedicine. 2023, 58:101882. 10.1016\/j.eclinm.2023.101882","journal-title":"EClinicalMedicine"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk FZ","year":"2013","unstructured":"Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013, 34:171-208. 10.1210\/er.2012-1008","journal-title":"Endocr Rev"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.21.2.262","article-title":"Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial","volume":"21","author":"Angerer P","year":"2001","unstructured":"Angerer P, St\u00f6rk S, Kothny W, Schmitt P, von Schacky C. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial. Arterioscler Thromb Vasc Biol. 2001, 21:262-8. 10.1161\/01.atv.21.2.262","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review","volume":"94","author":"Horton LG","year":"2016","unstructured":"Horton LG, Simmons KB, Curtis KM. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review. Contraception. 2016, 94:590-604. 10.1016\/j.contraception.2016.05.014","journal-title":"Contraception"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275734-the-impact-of-hormonal-contraceptives-on-the-incidence-and-progression-of-cardiovascular-diseases-in-women-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T12:27:28Z","timestamp":1721910448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275734-the-impact-of-hormonal-contraceptives-on-the-incidence-and-progression-of-cardiovascular-diseases-in-women-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.65366","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}